ESR1 and ovarian carcinoma: Furthermore, ERα expression was also observed in human ovarian cancer MDSCs, and E2-treated non-ovariectomized mice with ovarian cancer showed hastened tumor progression, with decreased levels of helper and cytotoxic T-cells, and increased concentrations of granulocytic MDSCs [174].